APO Research
Talk to an analyst

APO RESEARCH · REPORT

Coronavirus Spike Protein

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Coronavirus Spike Protein Industry Growth and Trends Forecast to 2032

29 December 2025104 pages

Choose your research edition.

Industry ResearchCoronavirus Spike Protein Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Coronavirus Spike Protein Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Coronavirus Spike Protein Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Coronavirus Spike Protein Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Coronavirus Spike Protein Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Coronavirus Spike Protein market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Coronavirus Spike Protein is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Coronavirus Spike Protein is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Coronavirus Spike Protein is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Coronavirus Spike Protein include Seebio, Sanofi, Thermo Fisher Scientific, The Native Antigen Company, Sinobiological, Novus Biologicals, Merck KGaA (Sigma-Aldrich), Elabscience and Eagle Biosciences, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Coronavirus Spike Protein market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Coronavirus Spike Protein market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Coronavirus Spike Protein market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Coronavirus Spike Protein.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Coronavirus Spike Protein market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Coronavirus Spike Protein Market by Company

Seebio

Sanofi

Thermo Fisher Scientific

The Native Antigen Company

Sinobiological

Novus Biologicals

Merck KGaA (Sigma-Aldrich)

Elabscience

Eagle Biosciences

BiosPacific

Bio-Rad Laboratories

Agrisera

Abcam

Coronavirus Spike Protein Segment by Type

90%≤Purity≤95%

Purity＞95%

Other

Coronavirus Spike Protein Segment by Application

RDT & ELISA

Antiviral Drugs

Research

Vaccine Development

Other

Coronavirus Spike Protein Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Coronavirus Spike Protein market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Coronavirus Spike Protein and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Coronavirus Spike Protein.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Coronavirus Spike Protein manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Coronavirus Spike Protein in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 90%≤Purity≤95% Table 2. Major Company of Purity＞95% Table 3. Major Company of Other Table 4. Global Coronavirus Spike Protein Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Coronavirus Spike Protein Sales by Type (2021-2026) & (K Units) Table 6. Global Coronavirus Spike Protein Sales Market Share in Volume by Type (2021-2026) Table 7. Global Coronavirus Spike Protein Sales by Type (2021-2026) & (US$ Million) Table 8. Global Coronavirus Spike Protein Sales Market Share in Value by Type (2021-2026) Table 9. Global Coronavirus Spike Protein Price by Type (2021-2026) & (US$/Unit) Table 10. Global Coronavirus Spike Protein Sales by Type (2027-2032) & (K Units) Table 11. Global Coronavirus Spike Protein Sales Market Share in Volume by Type (2027-2032) Table 12. Global Coronavirus Spike Protein Sales by Type (2027-2032) & (US$ Million) Table 13. Global Coronavirus Spike Protein Sales Market Share in Value by Type (2027-2032) Table 14. Global Coronavirus Spike Protein Price by Type (2027-2032) & (US$/Unit) Table 15. North America Coronavirus Spike Protein Sales by Type (2021-2026) & (K Units) Table 16. North America Coronavirus Spike Protein Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Coronavirus Spike Protein Sales by Type (2021-2026) & (K Units) Table 18. Europe Coronavirus Spike Protein Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Coronavirus Spike Protein Sales by Type (2021-2026) & (K Units) Table 20. Asia-Pacific Coronavirus Spike Protein Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Coronavirus Spike Protein Sales by Type (2021-2026) & (K Units) Table 22. Latin America Coronavirus Spike Protein Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Coronavirus Spike Protein Sales by Type (2021-2026) & (K Units) Table 24. Middle East and Africa Coronavirus Spike Protein Sales by Type (2021-2026) & (US$ Million) Table 25. Coronavirus Spike Protein Industry Trends Table 26. Coronavirus Spike Protein Industry Drivers Table 27. Coronavirus Spike Protein Industry Opportunities and Challenges Table 28. Coronavirus Spike Protein Industry Restraints Table 29. Global Coronavirus Spike Protein Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Coronavirus Spike Protein Revenue Market Share by Company (2021-2026) Table 31. Global Coronavirus Spike Protein Sales by Company (2021-2026) & (K Units) Table 32. Global Coronavirus Spike Protein Sales Share by Company (2021-2026) Table 33. Global Coronavirus Spike Protein Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Coronavirus Spike Protein Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Coronavirus Spike Protein Major Company Production Sites and Headquarters Table 36. Global Coronavirus Spike Protein Company, Product Type & Application Table 37. Global Coronavirus Spike Protein Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Coronavirus Spike Protein by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Coronavirus Spike Protein Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Coronavirus Spike Protein Sales by Region (2021-2026) & (K Units) Table 42. Global Coronavirus Spike Protein Sales Market Share in Volume by Region (2021-2026) Table 43. Global Coronavirus Spike Protein Sales by Region (2021-2026) & (US$ Million) Table 44. Global Coronavirus Spike Protein Sales Market Share in Value by Region (2021-2026) Table 45. Global Coronavirus Spike Protein Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Coronavirus Spike Protein Sales by Region (2027-2032) & (K Units) Table 47. Global Coronavirus Spike Protein Sales Market Share in Volume by Region (2027-2032) Table 48. Global Coronavirus Spike Protein Sales by Region (2027-2032) & (US$ Million) Table 49. Global Coronavirus Spike Protein Sales Market Share in Value by Region (2027-2032) Table 50. Global Coronavirus Spike Protein Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Coronavirus Spike Protein Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Coronavirus Spike Protein Sales by Application (2021-2026) & (K Units) Table 53. Global Coronavirus Spike Protein Sales Market Share in Volume by Application (2021-2026) Table 54. Global Coronavirus Spike Protein Sales by Application (2021-2026) & (US$ Million) Table 55. Global Coronavirus Spike Protein Sales Market Share in Value by Application (2021-2026) Table 56. Global Coronavirus Spike Protein Price by Application (2021-2026) & (US$/Unit) Table 57. Global Coronavirus Spike Protein Sales by Application (2027-2032) & (K Units) Table 58. Global Coronavirus Spike Protein Sales Market Share in Volume by Application (2027-2032) Table 59. Global Coronavirus Spike Protein Sales by Application (2027-2032) & (US$ Million) Table 60. Global Coronavirus Spike Protein Sales Market Share in Value by Application (2027-2032) Table 61. Global Coronavirus Spike Protein Price by Application (2027-2032) & (US$/Unit) Table 62. North America Coronavirus Spike Protein Sales by Application (2021-2026) & (K Units) Table 63. North America Coronavirus Spike Protein Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Coronavirus Spike Protein Sales by Application (2021-2026) & (K Units) Table 65. Europe Coronavirus Spike Protein Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Coronavirus Spike Protein Sales by Application (2021-2026) & (K Units) Table 67. Asia-Pacific Coronavirus Spike Protein Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Coronavirus Spike Protein Sales by Application (2021-2026) & (K Units) Table 69. Latin America Coronavirus Spike Protein Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Coronavirus Spike Protein Sales by Application (2021-2026) & (K Units) Table 71. Middle East and Africa Coronavirus Spike Protein Sales by Application (2021-2026) & (US$ Million) Table 72. Seebio Company Information Table 73. Seebio Business Overview Table 74. Seebio Coronavirus Spike Protein Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Seebio Coronavirus Spike Protein Product Portfolio Table 76. Seebio Recent Development Table 77. Sanofi Company Information Table 78. Sanofi Business Overview Table 79. Sanofi Coronavirus Spike Protein Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Sanofi Coronavirus Spike Protein Product Portfolio Table 81. Sanofi Recent Development Table 82. Thermo Fisher Scientific Company Information Table 83. Thermo Fisher Scientific Business Overview Table 84. Thermo Fisher Scientific Coronavirus Spike Protein Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Thermo Fisher Scientific Coronavirus Spike Protein Product Portfolio Table 86. Thermo Fisher Scientific Recent Development Table 87. The Native Antigen Company Company Information Table 88. The Native Antigen Company Business Overview Table 89. The Native Antigen Company Coronavirus Spike Protein Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. The Native Antigen Company Coronavirus Spike Protein Product Portfolio Table 91. The Native Antigen Company Recent Development Table 92. Sinobiological Company Information Table 93. Sinobiological Business Overview Table 94. Sinobiological Coronavirus Spike Protein Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Sinobiological Coronavirus Spike Protein Product Portfolio Table 96. Sinobiological Recent Development Table 97. Novus Biologicals Company Information Table 98. Novus Biologicals Business Overview Table 99. Novus Biologicals Coronavirus Spike Protein Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Novus Biologicals Coronavirus Spike Protein Product Portfolio Table 101. Novus Biologicals Recent Development Table 102. Merck KGaA (Sigma-Aldrich) Company Information Table 103. Merck KGaA (Sigma-Aldrich) Business Overview Table 104. Merck KGaA (Sigma-Aldrich) Coronavirus Spike Protein Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Merck KGaA (Sigma-Aldrich) Coronavirus Spike Protein Product Portfolio Table 106. Merck KGaA (Sigma-Aldrich) Recent Development Table 107. Elabscience Company Information Table 108. Elabscience Business Overview Table 109. Elabscience Coronavirus Spike Protein Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Elabscience Coronavirus Spike Protein Product Portfolio Table 111. Elabscience Recent Development Table 112. Eagle Biosciences Company Information Table 113. Eagle Biosciences Business Overview Table 114. Eagle Biosciences Coronavirus Spike Protein Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Eagle Biosciences Coronavirus Spike Protein Product Portfolio Table 116. Eagle Biosciences Recent Development Table 117. BiosPacific Company Information Table 118. BiosPacific Business Overview Table 119. BiosPacific Coronavirus Spike Protein Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. BiosPacific Coronavirus Spike Protein Product Portfolio Table 121. BiosPacific Recent Development Table 122. Bio-Rad Laboratories Company Information Table 123. Bio-Rad Laboratories Business Overview Table 124. Bio-Rad Laboratories Coronavirus Spike Protein Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. Bio-Rad Laboratories Coronavirus Spike Protein Product Portfolio Table 126. Bio-Rad Laboratories Recent Development Table 127. Agrisera Company Information Table 128. Agrisera Business Overview Table 129. Agrisera Coronavirus Spike Protein Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 130. Agrisera Coronavirus Spike Protein Product Portfolio Table 131. Agrisera Recent Development Table 132. Abcam Company Information Table 133. Abcam Business Overview Table 134. Abcam Coronavirus Spike Protein Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 135. Abcam Coronavirus Spike Protein Product Portfolio Table 136. Abcam Recent Development Table 137. North America Coronavirus Spike Protein Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 138. North America Coronavirus Spike Protein Sales by Country (2021-2026) & (K Units) Table 139. North America Coronavirus Spike Protein Sales Market Share by Country (2021-2026) Table 140. North America Coronavirus Spike Protein Sales Forecast by Country (2027-2032) & (K Units) Table 141. North America Coronavirus Spike Protein Sales Market Share Forecast by Country (2027-2032) Table 142. North America Coronavirus Spike Protein Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 143. North America Coronavirus Spike Protein Market Size by Country (2021-2026) & (US$ Million) Table 144. North America Coronavirus Spike Protein Market Share by Country (2021-2026) Table 145. North America Coronavirus Spike Protein Market Size Forecast by Country (2027-2032) & (US$ Million) Table 146. North America Coronavirus Spike Protein Market Share Forecast by Country (2027-2032) Table 147. Europe Coronavirus Spike Protein Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 148. Europe Coronavirus Spike Protein Sales by Country (2021-2026) & (K Units) Table 149. Europe Coronavirus Spike Protein Sales Market Share by Country (2021-2026) Table 150. Europe Coronavirus Spike Protein Sales Forecast by Country (2027-2032) & (K Units) Table 151. Europe Coronavirus Spike Protein Sales Market Share Forecast by Country (2027-2032) Table 152. Europe Coronavirus Spike Protein Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 153. Europe Coronavirus Spike Protein Market Size by Country (2021-2026) & (US$ Million) Table 154. Europe Coronavirus Spike Protein Market Share by Country (2021-2026) Table 155. Europe Coronavirus Spike Protein Market Size Forecast by Country (2027-2032) & (US$ Million) Table 156. Europe Coronavirus Spike Protein Market Share Forecast by Country (2027-2032) Table 157. Asia-Pacific Coronavirus Spike Protein Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 158. Asia-Pacific Coronavirus Spike Protein Sales by Country (2021-2026) & (K Units) Table 159. Asia-Pacific Coronavirus Spike Protein Sales Market Share by Country (2021-2026) Table 160. Asia-Pacific Coronavirus Spike Protein Sales Forecast by Country (2027-2032) & (K Units) Table 161. Asia-Pacific Coronavirus Spike Protein Sales Market Share Forecast by Country (2027-2032) Table 162. Asia-Pacific Coronavirus Spike Protein Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 163. Asia-Pacific Coronavirus Spike Protein Market Size by Country (2021-2026) & (US$ Million) Table 164. Asia-Pacific Coronavirus Spike Protein Market Share by Country (2021-2026) Table 165. Asia-Pacific Coronavirus Spike Protein Market Size Forecast by Country (2027-2032) & (US$ Million) Table 166. Asia-Pacific Coronavirus Spike Protein Market Share Forecast by Country (2027-2032) Table 167. Latin America Coronavirus Spike Protein Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 168. Latin America Coronavirus Spike Protein Sales by Country (2021-2026) & (K Units) Table 169. Latin America Coronavirus Spike Protein Sales Market Share by Country (2021-2026) Table 170. Latin America Coronavirus Spike Protein Sales Forecast by Country (2027-2032) & (K Units) Table 171. Latin America Coronavirus Spike Protein Sales Market Share Forecast by Country (2027-2032) Table 172. Latin America Coronavirus Spike Protein Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 173. Latin America Coronavirus Spike Protein Market Size by Country (2021-2026) & (US$ Million) Table 174. Latin America Coronavirus Spike Protein Market Share by Country (2021-2026) Table 175. Latin America Coronavirus Spike Protein Market Size Forecast by Country (2027-2032) & (US$ Million) Table 176. Latin America Coronavirus Spike Protein Market Share Forecast by Country (2027-2032) Table 177. Middle East and Africa Coronavirus Spike Protein Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 178. Middle East and Africa Coronavirus Spike Protein Sales by Country (2021-2026) & (K Units) Table 179. Middle East and Africa Coronavirus Spike Protein Sales Market Share by Country (2021-2026) Table 180. Middle East and Africa Coronavirus Spike Protein Sales Forecast by Country (2027-2032) & (K Units) Table 181. Middle East and Africa Coronavirus Spike Protein Sales Market Share Forecast by Country (2027-2032) Table 182. Middle East and Africa Coronavirus Spike Protein Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 183. Middle East and Africa Coronavirus Spike Protein Market Size by Country (2021-2026) & (US$ Million) Table 184. Middle East and Africa Coronavirus Spike Protein Market Share by Country (2021-2026) Table 185. Middle East and Africa Coronavirus Spike Protein Market Size Forecast by Country (2027-2032) & (US$ Million) Table 186. Middle East and Africa Coronavirus Spike Protein Market Share Forecast by Country (2027-2032) Table 187. Key Raw Materials Table 188. Raw Materials Key Suppliers Table 189. Coronavirus Spike Protein Distributors List Table 190. Coronavirus Spike Protein Customers List Table 191. Research Programs/Design for This Report Table 192. Authors List of This Report Table 193. Secondary Sources Table 194. Primary Sources List of Figures Figure 1. Coronavirus Spike Protein Image Figure 2. Global Coronavirus Spike Protein Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Coronavirus Spike Protein Market Size (2021-2032) & (US$ Million) Figure 4. Global Coronavirus Spike Protein Sales (2021-2032) & (K Units) Figure 5. 90%≤Purity≤95% Image Figure 6. Global 90%≤Purity≤95% Sales YoY Growth (2021-2032) & (K Units) Figure 7. Purity＞95% Image Figure 8. Global Purity＞95% Sales YoY Growth (2021-2032) & (K Units) Figure 9. Other Image Figure 10. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 11. Global Coronavirus Spike Protein Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Coronavirus Spike Protein Market Share by Type 2025 VS 2032 Figure 13. North America Coronavirus Spike Protein Sales Market Share in Volume by Type in 2025 Figure 14. North America Coronavirus Spike Protein Sales Market Share in Value by Type in 2025 Figure 15. Europe Coronavirus Spike Protein Sales Market Share in Volume by Type in 2025 Figure 16. Europe Coronavirus Spike Protein Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Coronavirus Spike Protein Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Coronavirus Spike Protein Sales Market Share in Value by Type in 2025 Figure 19. Latin America Coronavirus Spike Protein Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Coronavirus Spike Protein Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Coronavirus Spike Protein Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Coronavirus Spike Protein Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Coronavirus Spike Protein Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. RDT & ELISA Image Figure 26. Global RDT & ELISA Sales YoY Growth (2021-2032) & (K Units) Figure 27. Antiviral Drugs Image Figure 28. Global Antiviral Drugs Sales YoY Growth (2021-2032) & (K Units) Figure 29. Research Image Figure 30. Global Research Sales YoY Growth (2021-2032) & (K Units) Figure 31. Vaccine Development Image Figure 32. Global Vaccine Development Sales YoY Growth (2021-2032) & (K Units) Figure 33. Other Image Figure 34. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 35. Global Coronavirus Spike Protein Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Coronavirus Spike Protein Market Share by Application 2025 VS 2032 Figure 37. North America Coronavirus Spike Protein Sales Market Share in Volume by Application in 2025 Figure 38. North America Coronavirus Spike Protein Sales Market Share in Value by Application in 2025 Figure 39. Europe Coronavirus Spike Protein Sales Market Share in Volume by Application in 2025 Figure 40. Europe Coronavirus Spike Protein Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific Coronavirus Spike Protein Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific Coronavirus Spike Protein Sales Market Share in Value by Application in 2025 Figure 43. Latin America Coronavirus Spike Protein Sales Market Share in Volume by Application in 2025 Figure 44. Latin America Coronavirus Spike Protein Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa Coronavirus Spike Protein Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa Coronavirus Spike Protein Sales Market Share in Value by Application in 2025 Figure 47. North America Coronavirus Spike Protein Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. North America Coronavirus Spike Protein Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America Coronavirus Spike Protein Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America Coronavirus Spike Protein Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Coronavirus Spike Protein Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Europe Coronavirus Spike Protein Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Coronavirus Spike Protein Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe Coronavirus Spike Protein Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Coronavirus Spike Protein Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Asia-Pacific Coronavirus Spike Protein Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Coronavirus Spike Protein Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific Coronavirus Spike Protein Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Coronavirus Spike Protein Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Latin America Coronavirus Spike Protein Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Coronavirus Spike Protein Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America Coronavirus Spike Protein Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Coronavirus Spike Protein Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 64. Middle East and Africa Coronavirus Spike Protein Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Coronavirus Spike Protein Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa Coronavirus Spike Protein Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Coronavirus Spike Protein Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. Coronavirus Spike Protein Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • 90%≤Purity≤95%
  • Purity＞95%
  • Other
Applications
  • RDT & ELISA
  • Antiviral Drugs
  • Research
  • Vaccine Development
  • Other
Companies covered
  • Seebio
  • Sanofi
  • Thermo Fisher Scientific
  • The Native Antigen Company
  • Sinobiological
  • Novus Biologicals
  • Merck KGaA (Sigma-Aldrich)
  • Elabscience
  • Eagle Biosciences
  • BiosPacific
  • Bio-Rad Laboratories
  • Agrisera
  • Abcam

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Coronavirus Spike Protein Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Coronavirus Spike Protein Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Coronavirus Spike Protein Market by Type
  6. 1.3.1 90%≤Purity≤95%
  7. 1.3.2 Purity＞95%
  8. 1.3.3 Other
  9. 1.4 Global Coronavirus Spike Protein Market Size by Type
  10. 1.4.1 Global Coronavirus Spike Protein Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Coronavirus Spike Protein Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Coronavirus Spike Protein Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Coronavirus Spike Protein Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Coronavirus Spike Protein Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Coronavirus Spike Protein Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Coronavirus Spike Protein Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Coronavirus Spike Protein Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Coronavirus Spike Protein Industry Trends
  2. 2.2 Coronavirus Spike Protein Industry Drivers
  3. 2.3 Coronavirus Spike Protein Industry Opportunities and Challenges
  4. 2.4 Coronavirus Spike Protein Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Coronavirus Spike Protein Revenue (2021-2026)
  2. 3.2 Global Top Players by Coronavirus Spike Protein Sales (2021-2026)
  3. 3.3 Global Top Players by Coronavirus Spike Protein Price (2021-2026)
  4. 3.4 Global Coronavirus Spike Protein Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Coronavirus Spike Protein Major Company Production Sites & Headquarters
  6. 3.6 Global Coronavirus Spike Protein Company, Product Type & Application
  7. 3.7 Global Coronavirus Spike Protein Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Coronavirus Spike Protein Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Coronavirus Spike Protein Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Coronavirus Spike Protein Tier 1, Tier 2, and Tier 3
4 Coronavirus Spike Protein Regional Status and Outlook
  1. 4.1 Global Coronavirus Spike Protein Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Coronavirus Spike Protein Historic Market Size by Region
  3. 4.2.1 Global Coronavirus Spike Protein Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Coronavirus Spike Protein Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Coronavirus Spike Protein Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Coronavirus Spike Protein Forecasted Market Size by Region
  7. 4.3.1 Global Coronavirus Spike Protein Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Coronavirus Spike Protein Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Coronavirus Spike Protein Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Coronavirus Spike Protein by Application
  1. 5.1 Coronavirus Spike Protein Market by Application
  2. 5.1.1 RDT & ELISA
  3. 5.1.2 Antiviral Drugs
  4. 5.1.3 Research
  5. 5.1.4 Vaccine Development
  6. 5.1.5 Other
  7. 5.2 Global Coronavirus Spike Protein Market Size by Application
  8. 5.2.1 Global Coronavirus Spike Protein Market Size Overview by Application (2021-2032)
  9. 5.2.2 Global Coronavirus Spike Protein Historic Market Size Review by Application (2021-2026)
  10. 5.2.3 Global Coronavirus Spike Protein Forecasted Market Size by Application (2027-2032)
  11. 5.3 Key Regions Market Size by Application
  12. 5.3.1 North America Coronavirus Spike Protein Sales Breakdown by Application (2021-2026)
  13. 5.3.2 Europe Coronavirus Spike Protein Sales Breakdown by Application (2021-2026)
  14. 5.3.3 Asia-Pacific Coronavirus Spike Protein Sales Breakdown by Application (2021-2026)
  15. 5.3.4 South America Coronavirus Spike Protein Sales Breakdown by Application (2021-2026)
  16. 5.3.5 Middle East and Africa Coronavirus Spike Protein Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Seebio
  2. 6.1.1 Seebio Company Information
  3. 6.1.2 Seebio Business Overview
  4. 6.1.3 Seebio Coronavirus Spike Protein Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Seebio Coronavirus Spike Protein Product Portfolio
  6. 6.1.5 Seebio Recent Developments
  7. 6.2 Sanofi
  8. 6.2.1 Sanofi Company Information
  9. 6.2.2 Sanofi Business Overview
  10. 6.2.3 Sanofi Coronavirus Spike Protein Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Sanofi Coronavirus Spike Protein Product Portfolio
  12. 6.2.5 Sanofi Recent Developments
  13. 6.3 Thermo Fisher Scientific
  14. 6.3.1 Thermo Fisher Scientific Company Information
  15. 6.3.2 Thermo Fisher Scientific Business Overview
  16. 6.3.3 Thermo Fisher Scientific Coronavirus Spike Protein Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Thermo Fisher Scientific Coronavirus Spike Protein Product Portfolio
  18. 6.3.5 Thermo Fisher Scientific Recent Developments
  19. 6.4 The Native Antigen Company
  20. 6.4.1 The Native Antigen Company Company Information
  21. 6.4.2 The Native Antigen Company Business Overview
  22. 6.4.3 The Native Antigen Company Coronavirus Spike Protein Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 The Native Antigen Company Coronavirus Spike Protein Product Portfolio
  24. 6.4.5 The Native Antigen Company Recent Developments
  25. 6.5 Sinobiological
  26. 6.5.1 Sinobiological Company Information
  27. 6.5.2 Sinobiological Business Overview
  28. 6.5.3 Sinobiological Coronavirus Spike Protein Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Sinobiological Coronavirus Spike Protein Product Portfolio
  30. 6.5.5 Sinobiological Recent Developments
  31. 6.6 Novus Biologicals
  32. 6.6.1 Novus Biologicals Company Information
  33. 6.6.2 Novus Biologicals Business Overview
  34. 6.6.3 Novus Biologicals Coronavirus Spike Protein Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Novus Biologicals Coronavirus Spike Protein Product Portfolio
  36. 6.6.5 Novus Biologicals Recent Developments
  37. 6.7 Merck KGaA (Sigma-Aldrich)
  38. 6.7.1 Merck KGaA (Sigma-Aldrich) Company Information
  39. 6.7.2 Merck KGaA (Sigma-Aldrich) Business Overview
  40. 6.7.3 Merck KGaA (Sigma-Aldrich) Coronavirus Spike Protein Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Merck KGaA (Sigma-Aldrich) Coronavirus Spike Protein Product Portfolio
  42. 6.7.5 Merck KGaA (Sigma-Aldrich) Recent Developments
  43. 6.8 Elabscience
  44. 6.8.1 Elabscience Company Information
  45. 6.8.2 Elabscience Business Overview
  46. 6.8.3 Elabscience Coronavirus Spike Protein Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Elabscience Coronavirus Spike Protein Product Portfolio
  48. 6.8.5 Elabscience Recent Developments
  49. 6.9 Eagle Biosciences
  50. 6.9.1 Eagle Biosciences Company Information
  51. 6.9.2 Eagle Biosciences Business Overview
  52. 6.9.3 Eagle Biosciences Coronavirus Spike Protein Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Eagle Biosciences Coronavirus Spike Protein Product Portfolio
  54. 6.9.5 Eagle Biosciences Recent Developments
  55. 6.10 BiosPacific
  56. 6.10.1 BiosPacific Company Information
  57. 6.10.2 BiosPacific Business Overview
  58. 6.10.3 BiosPacific Coronavirus Spike Protein Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 BiosPacific Coronavirus Spike Protein Product Portfolio
  60. 6.10.5 BiosPacific Recent Developments
  61. 6.11 Bio-Rad Laboratories
  62. 6.11.1 Bio-Rad Laboratories Company Information
  63. 6.11.2 Bio-Rad Laboratories Business Overview
  64. 6.11.3 Bio-Rad Laboratories Coronavirus Spike Protein Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Bio-Rad Laboratories Coronavirus Spike Protein Product Portfolio
  66. 6.11.5 Bio-Rad Laboratories Recent Developments
  67. 6.12 Agrisera
  68. 6.12.1 Agrisera Company Information
  69. 6.12.2 Agrisera Business Overview
  70. 6.12.3 Agrisera Coronavirus Spike Protein Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Agrisera Coronavirus Spike Protein Product Portfolio
  72. 6.12.5 Agrisera Recent Developments
  73. 6.13 Abcam
  74. 6.13.1 Abcam Company Information
  75. 6.13.2 Abcam Business Overview
  76. 6.13.3 Abcam Coronavirus Spike Protein Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Abcam Coronavirus Spike Protein Product Portfolio
  78. 6.13.5 Abcam Recent Developments
7 North America by Country
  1. 7.1 North America Coronavirus Spike Protein Sales by Country
  2. 7.1.1 North America Coronavirus Spike Protein Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Coronavirus Spike Protein Sales by Country (2021-2026)
  4. 7.1.3 North America Coronavirus Spike Protein Sales Forecast by Country (2027-2032)
  5. 7.2 North America Coronavirus Spike Protein Market Size by Country
  6. 7.2.1 North America Coronavirus Spike Protein Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Coronavirus Spike Protein Market Size by Country (2021-2026)
  8. 7.2.3 North America Coronavirus Spike Protein Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Coronavirus Spike Protein Sales by Country
  2. 8.1.1 Europe Coronavirus Spike Protein Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Coronavirus Spike Protein Sales by Country (2021-2026)
  4. 8.1.3 Europe Coronavirus Spike Protein Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Coronavirus Spike Protein Market Size by Country
  6. 8.2.1 Europe Coronavirus Spike Protein Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Coronavirus Spike Protein Market Size by Country (2021-2026)
  8. 8.2.3 Europe Coronavirus Spike Protein Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Coronavirus Spike Protein Sales by Country
  2. 9.1.1 Asia-Pacific Coronavirus Spike Protein Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Coronavirus Spike Protein Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Coronavirus Spike Protein Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Coronavirus Spike Protein Market Size by Country
  6. 9.2.1 Asia-Pacific Coronavirus Spike Protein Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Coronavirus Spike Protein Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Coronavirus Spike Protein Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Coronavirus Spike Protein Sales by Country
  2. 10.1.1 South America Coronavirus Spike Protein Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Coronavirus Spike Protein Sales by Country (2021-2026)
  4. 10.1.3 South America Coronavirus Spike Protein Sales Forecast by Country (2027-2032)
  5. 10.2 South America Coronavirus Spike Protein Market Size by Country
  6. 10.2.1 South America Coronavirus Spike Protein Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Coronavirus Spike Protein Market Size by Country (2021-2026)
  8. 10.2.3 South America Coronavirus Spike Protein Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Coronavirus Spike Protein Sales by Country
  2. 11.1.1 Middle East and Africa Coronavirus Spike Protein Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Coronavirus Spike Protein Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Coronavirus Spike Protein Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Coronavirus Spike Protein Market Size by Country
  6. 11.2.1 Middle East and Africa Coronavirus Spike Protein Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Coronavirus Spike Protein Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Coronavirus Spike Protein Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Coronavirus Spike Protein Value Chain Analysis
  2. 12.1.1 Coronavirus Spike Protein Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Coronavirus Spike Protein Production Mode & Process
  7. 12.2 Coronavirus Spike Protein Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Coronavirus Spike Protein Distributors
  10. 12.2.3 Coronavirus Spike Protein Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst